Syndax Pharmaceuticals (SNDX) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced with introductions of board members, executive team, and auditors present for the session.

• Agenda included formal business, voting on proposals, and a Q&A session for stockholders.

Board and executive committee updates

• Board members and executive officers were introduced, including CEO, CFO, general counsel, and external auditors.

Shareholder proposals

• Five proposals were presented: election of two class 1 directors, advisory approval of executive compensation, ratification of independent auditors, approval of the 2026 Equity Incentive Plan, and approval of the 2026 Employee Stock Purchase Plan.